Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Roivant Sciences (ROIV) Short-Term Debt issuances: 2020-2022

  • Roivant Sciences' Short-Term Debt issuances rose 339.28% to $159.9 million in Q4 2022 from the same period last year, while for Dec 2022 it was $392.6 million, marking a year-over-year change of. This contributed to the annual value of $159.9 million for FY2023, which is 339.28% up from last year.
  • According to the latest figures from Q4 2022, Roivant Sciences' Short-Term Debt issuances is $159.9 million, which was down 0.00% from $159.9 million recorded in Q2 2022.
  • Roivant Sciences' Short-Term Debt issuances' 5-year high stood at $159.9 million during Q2 2022, with a 5-year trough of -$36.4 million in Q4 2020.
  • In the last 3 years, Roivant Sciences' Short-Term Debt issuances had a median value of $36.4 million in 2021 and averaged $71.2 million.
  • Data for Roivant Sciences' Short-Term Debt issuances shows a peak YoY surged of 339.28% (in 2022) over the last 5 years.
  • Quarterly analysis of 3 years shows Roivant Sciences' Short-Term Debt issuances stood at -$36.4 million in 2020, then surged by 200.00% to $36.4 million in 2021, then surged by 339.28% to $159.9 million in 2022.
  • Its last three reported values are $159.9 million in Q4 2022, $159.9 million for Q2 2022, and $36.4 million during Q4 2021.